Titlebook: Monoclonal Antibodies in Headache; From Bench to Patien Antoinette Maassen van den Brink,Paolo Martelletti Book 2021 Springer Nature Switze

Obsolescent

書目名稱Monoclonal Antibodies in Headache影響因子(影響力)




書目名稱Monoclonal Antibodies in Headache影響因子(影響力)學(xué)科排名




書目名稱Monoclonal Antibodies in Headache網(wǎng)絡(luò)公開度




書目名稱Monoclonal Antibodies in Headache網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Monoclonal Antibodies in Headache被引頻次




書目名稱Monoclonal Antibodies in Headache被引頻次學(xué)科排名




書目名稱Monoclonal Antibodies in Headache年度引用




書目名稱Monoclonal Antibodies in Headache年度引用學(xué)科排名




書目名稱Monoclonal Antibodies in Headache讀者反饋




書目名稱Monoclonal Antibodies in Headache讀者反饋學(xué)科排名

蝕刻術(shù)

https://doi.org/10.1007/978-3-030-69032-8Migraine; Cluster headache; CGRP; Galcanezumab; Eptinezumab; Erenumab; Fremanezumab; psychopharmacology

熱心

978-3-030-69034-2Springer Nature Switzerland AG 2021

蠟燭

Monoclonal Antibodies in Headache978-3-030-69032-8Series ISSN 2197-652X Series E-ISSN 2197-6538

使虛弱

PHON

2197-652X -day real-world use. Given its scope, the book will appeal to a broad range of specialists, including pharmacologists, clinical pharmacologists, neurologists and internists, but also to residents and medical students.978-3-030-69034-2978-3-030-69032-8Series ISSN 2197-652X Series E-ISSN 2197-6538

自作多情

Book 2021es in this context. Authored by the most respected migraine experts from around the globe and drawing on the lessons learned in both clinical trials and clinical practice, it reviews the current state of knowledge on this important therapeutic innovation, which has produced impressive data in random

STALL

agenda

2197-652X dels, and the four molecules in the group.Places major emphaIntended to promote a more appropriate and modern therapeutic approach to migraine management, this book is the first to deal with monoclonal antibodies in this context. Authored by the most respected migraine experts from around the globe

Platelet

10樓